Explore Recursion Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RXRX. Recursion reported second-quarter revenue of $19.22 million, beating ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback